Empery Asset Management, LP

Fundamental concentrated ★Signal healthcare specialist (67%) CIK 1469336
League rank
#344
in Fundamental concentrated · #1710 overall
Long book
$83.0M
Q1 2026
Positions
32
Top-10 weight
92%
concentration
Last quarter
+4.6%
SPY +14.8%
Turnover
57%
of book per quarter

Strategy in plain words

auto-generated from filings

Empery Asset Management, LP is a concentrated fundamental stock-picker, specialised in healthcare (67% of the long book), running a $83.0M US long book across 32 positions.

The portfolio is extremely concentrated — the top 10 positions are almost the whole book. Turnover is high — positions rotate quickly, so individual names matter less than the process. Current anchor positions: X4 PHARMACEUTICALS INC, EMPERY DIGITAL INC, PRECISION BIOSCIENCES INC, IMPERIAL PETROLEUM INC, VENU HOLDING CORP.

We rate its filings as signal-bearing: position changes reflect genuine views.

Implied long-book return vs S&P 500

methodology: positions priced quarterly, no shorts/options
Fund long book S&P 500
Q4 2025
+0.2%
Q1 2026
+4.6%

Sector allocation

Healthcare
67%
Financials
15%
Industrials
5%
Services media
4%
Materials
4%
Technology
3%
Energy
2%

Long book by quarter

$113.4M
Q4 2025
$83.0M
Q1 2026

What does Empery Asset own?

Q1 2026 13F
CompanySectorSharesValue% of bookChange
XFOR X4 PHARMACEUTICALS INCHealthcare8.9M$36.9M44.5%-0.1%
EMPD EMPERY DIGITAL INCFinancials2.9M$12.4M14.9%Held
DTIL PRECISION BIOSCIENCES INCHealthcare2.0M$10.8M13.0%-10.3%
IMPP IMPERIAL PETROLEUM INCIndustrials877.6K$3.8M4.5%-72.4%
VENU VENU HOLDING CORPServices media1.0M$3.3M4.0%New
TNYA TENAYA THERAPEUTICS INCHealthcare4.3M$3.0M3.6%-20.8%
BSIN BIG SKY INDUSTRIAL INCEnergy1.9M$1.7M2.0%New
SCYX SCYNEXIS INCHealthcare1.8M$1.7M2.0%New
CYN CYNGN INCTechnology957.8K$1.6M1.9%New
JAGU JAGUAR URANIUM CORP-CL AMaterials487.5K$1.3M1.6%New
MSLE SATELLOS BIOSCIENCE INCHealthcare230.1K$1.3M1.6%New
CRML CRITICAL METALS CORPMaterials132.0K$1.0M1.3%-73.1%
URG UR-ENERGY INCMaterials620.1K$924K1.1%New
PMN PROMIS NEUROSCIENCES INCHealthcare60.4K$766K0.9%New
SLE SUPER LEAGUE ENTERPRISE INCTechnology132.9K$492K0.6%New
TLPH TALPHERA INCHealthcare590.5K$441K0.5%-55.7%
BNTC BENITEC BIOPHARMA INCHealthcare30.4K$324K0.4%-45.1%
ABTS ABITS GROUP INCFinancials172.8K$266K0.3%New
PRZO PARAZERO TECHNOLOGIES LTDIndustrials282.2K$218K0.3%New
NSRX NASUS PHARMA LTDHealthcare45.8K$102K0.1%New

13F filing history

PeriodFormFiledEntriesReported valueFlagsSource
Q1 202613F-HRMay 8, 202632$83.0M canonicalSEC ↗
Q4 202513F-HRFeb 11, 202631$113.4M canonicalSEC ↗